NCT05910411 Inelastic Compression in Edema After Revascularization
| NCT ID | NCT05910411 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Lymphedema |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-12-11 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-12-11 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The appearance of revascularization edema of the lower limb is a frequent complication in peripheral vascular surgery. It can lead to a delay in healing and even to trophic disorders. The prevention and treatment of this complication have so far been limited to postural measures (elevation of the limbs), in the absence of other recommendations and given the contraindication of elastic compression. Inelastic compression is another mode of compression sometimes used in the treatment of lymphedema. It exerts a stable continuous pressure regardless of the patient's position. The investigator's aim is to demonstrate that compression with inelastic bands, applied under good conditions, does not have a major effect on distal arterial vascularization in arterial patients who have undergone revascularization by supra-articular bypass or endovascular treatment of the lower limb.
Eligibility Criteria
Inclusion Criteria: 1. patients over 18 years of age 2. arteriopathic patients requiring femoropopliteal revascularization by bypass surgery who have been revascularized 3. signature of an informed consent 4. person affiliated or beneficiary of a social security plan Exclusion Criteria: 1. arterial bypasses under the leg or distal joints 2. critical ischemia 3. patients operated on for acute ischemia 4. pregnant or breast-feeding women 5. severe cardiac insufficiency 5\) severe peripheral neuropathy 6) allergies to the components of the tapes 7) persons deprived of liberty by judicial or administrative decision 8) persons under legal protection
Contact & Investigator
PASCAL GIORDANA
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Nice
Frequently Asked Questions
Who can join the NCT05910411 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Lymphedema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05910411 currently recruiting?
Yes, NCT05910411 is actively recruiting participants. Contact the research team at giordana.m@chu-nice.fr for enrollment information.
Where is the NCT05910411 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT05910411 clinical trial?
NCT05910411 is sponsored by Centre Hospitalier Universitaire de Nice. The principal investigator is PASCAL GIORDANA at Centre Hospitalier Universitaire de Nice. The trial plans to enroll 20 participants.